See other providers

Megan Murphy

Justin Zaghi MD/MBA

Khandi-Kae Sweeney

Ana Lisa Carr MD

Brittany Williams

Irene Kristal

Duyen Tran

Brett Garvey

Lillie Weaver

Mayra Garibay

Gloria Cabral

Katherine Kennedy Rostowsky

Amy Farabaugh

Sarah Masukewicz

James Kim

Erika Copeland

Melanie Hornung

Cynthia Coan

Devyn Hale

Jane Sylvestre

Mansi Parikh

Angela Cho

Nickisha Joyce

Dominic Zabell

Morgan Mertz

Madison Shaw

Sarah Jacobson

Vanessa Cordova

Ani Kourchians

Florate Hyatt-Israel

Megan Govedich

Amanda Murray

Flavia Souza
Visits: If we accept your insurance, your visits with our providers and dietitians are billed to your plan like any doctor’s visit, with no membership fee. You pay only your plan’s standard cost-sharing — copays, coinsurance, and deductible. We confirm whether we accept your plan when you sign up, and our billing team emails you a clear breakdown of what to expect.
Medications: If your Shapely provider determines that a GLP-1 is appropriate for you, coverage depends on your plan and medical conditions — but most patients have a path forward:
- Medicare: Through the Medicare GLP-1 Bridge (July 2026 – December 2027), eligible Part D members can fill prescriptions for Wegovy®, Zepbound®, and more for $50 a month. Outside the Bridge, Part D also covers GLP-1s for Type 2 diabetes, established cardiovascular disease, moderate-to-severe sleep apnea, and MASH with fibrosis. Learn more about the Bridge.
- Commercial insurance: Many plans cover GLP-1s for weight management with prior authorization; some exclude them. Copays vary by plan.
- If your plan doesn’t cover it: You still have options. We offer affordable self-pay medications so your care can continue without interruption.
If a GLP-1 is prescribed, we handle the prior authorization for you. Your exact medication cost isn’t known until your plan makes its decision, and we’ll walk you through it as soon as we hear back — including self-pay options if needed.
Shapely can help patients access self-pay programs for FDA-approved medications, such as Wegovy® through NovoCare® and Zepbound® through Lilly Direct®, which may offer discounted pricing for eligible patients.
In some cases, your provider may determine that a compounded medication is clinically appropriate based on your individual needs. When prescribed, compounded medications are offered on a self-pay basis, with pricing starting at $99 per month for compounded semaglutide and $166 per month for compounded tirzepatide.
Shapely is not affiliated with Novo Nordisk, Eli Lilly, or their patient programs. Compounded medications are not FDA-approved and are prepared by state-licensed pharmacies based on a provider’s clinical judgment.